December 28, 2015 (Shareholders Foundation) - An investigation on behalf of investors of Anavex Life Sciences Corp. (NASDAQ:AVXL) shares over potential securities laws violations by Anavex Life Sciences and certain of its directors and officers in connection certain financial statements was announced.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Anavex Life Sciences Corp. (NASDAQ:AVXL) concerning whether a series of statements by Anavex Life Sciences regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

On December 29, 2015, pre-market, Anavex Life Sciences Corp. (NASDAQ:AVXL) disclosed that it had received a subpoena from the U.S. Securities and Exchange Commission(SEC) on December 22, 2015. Anavex Life Sciences Corp. stated, in part, that '[t]he Company believes the subpoena and investigation relate to the recent unusual activity in the market for the Company's shares.'

Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) declined on December 28, 2015, to $6.50 per share.